SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

VIVO BIO TECH

BSE: 511509 29 Sep 2025
Healthcare
₹ 37
Vivo Bio tech Ltd. specializes in Biotechnology within the Healthcare sector.

VIVO BIO TECH - Share Price & Details

Market Cap
₹74.5
High /Low
56.9 / 31.2
Stock P/E
8.81
Book Value
₹45.4
Dividend Yield
0.0
ROCE
12.6
ROE
₹11.0
Face Value
10.0
PEG Ratio
0.18
EVEBITDA
₹4.79
Debt
54.0
CMP / FCF
15.5
Debt to equity
₹0.69
NP Ann
7.28
High price all time
115.0
Piotroski score
₹6.0
Graham Number
73.6
No. Eq. Shares
2.0
Net CF
₹-0.11
Net profit
8.45
Price to book value
0.82
Interest Coverage
₹2.42
Low price all time
9.25
Industry PE
61.6
Reserves
₹60.7
Free Cash Flow
₹-4.01

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
VIVO BIO TECH LTD.NANANANA74.58.81
VISTA PHARMACEUTICALS LTD.NANANANA70.4
WELCURE DRUGS & PHARMACEUTICALNANANANA68.22.46

Peer Comparison Chart


About VIVO BIO TECH

Vivo Bio tech Ltd., with Security Code 511509, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Why CLC Industries Limited Might Be One of the Best Stocks in Its Industry - Ex-Dividend Date Alerts & Explosive Profit Potential

(28 Sep 2025)
【Market Focus】✌️ Our expert forecasting and real-time tracking system puts 200%+ growth stocks right at your fingertips.
Read more →

Vivo Bio Tech Ltd Hidden Pharma Gem - Global Market Influence & Small Entry Cost Trading

(27 Sep 2025)
Vivo Bio Tech Ltd Hidden Pharma Gem ✌️【Stock Trends】✌️ Proven stock picks, backed by real performance — join investors who've already...
Read more →

Vivo Bio Tech secures pre-clinical testing contract valued at Rs.10.75 Cr

(23 Aug 2025)
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies.
Read more →

Pharma stock skyrockets 16% after receiving ₹10 Cr order for pre-clinical testing services

(20 Aug 2025)
Synopsis: Vivo Bio Tech announced securing a pre-clinical testing contract worth Rs 10.75 crore for providing its top-notch services to a...
Read more →

Vivo Bio Tech Ltd secures landmark Pre-Clinical Testing Contract Valued at ₹10.75 Crores

(20 Aug 2025)
Vivo Bio Tech Limited announces a significant milestone in its growth journey. The company has been awarded a pre-clinical testing contract...
Read more →

Vivo Bio Tech Reports Strong Growth Amid Liquidity Concerns in August 2025 Results

(14 Aug 2025)
Vivo Bio Tech has announced its financial results for the quarter ending June 2025, showcasing significant year-on-year growth in Profit...
Read more →